Kampala — Uganda has received a significant boost in its fight against major infectious diseases after the country secured a USD 521 million grant under the Global Fund’s Grant Cycle 8 (GC8) for the 2026–2028 period.
The announcement came during a courtesy meeting between the Permanent Secretary and Secretary to the Treasury, Ramathan Ggoobi, and Mr Linden Morrison, the Global Fund’s High-Impact Head for Africa, held at the Ministry of Finance headquarters in Kampala.
Mr Morrison was accompanied by Dr Eliud Wandwalo, Head of TB Programmes at the Global Fund, and Mr Dawson Kalemba of PricewaterhouseCoopers (PwC), the Local Fund Agent.
According to the Ministry of Finance, Planning and Economic Development, discussions focused on strengthening Uganda’s health financing systems and ensuring effective implementation of the new grant, which targets intensified interventions against HIV, tuberculosis, and malaria.
Ggoobi welcomed the continued partnership and emphasised Uganda’s commitment to accountability in managing donor funds.
“The PSST commended the partnership with the Global Fund and expressed appreciation for the grant of USD 521 million… He reiterated Uganda’s unwavering commitment to the highest levels of fiduciary assurance,” the ministry said in a statement.
Mr Morrison praised Uganda’s leadership in health service delivery and its contribution to regional health initiatives, noting the country’s strong implementation record under previous funding cycles.
He also urged the government to prioritise the sustainability of donor-supported programmes to ensure long-term impact beyond external financing.
“He urged the Government to focus on ensuring sustainability of interventions supported by the Global Fund and other partners,” the statement added.
The meeting was also attended by Johnson Mutesigensi, Coordinator of the Public Financial Management (PFM) Reforms Unit, who highlighted ongoing efforts to strengthen financial oversight systems.
The Global Fund partnership remains a key pillar in Uganda’s public health response, supporting nationwide efforts to reduce disease burden and improve access to treatment and prevention services.